In his Wall Street Journal Opinion piece, Dr. Angus Worthing discusses why capping co-payments is critically necessary to protect patient access to medications. He says many of his patients cannot afford their medications, with small co-pays evolving into co-insurance where the patient pays a percentage of the cost of each prescription. Dr. Worthing argues this system is designed to turn patients away from more effective, yet more costly, medications. Capping co-payments is essential because the burden of specialty drug costs should not be placed on the shoulders of people suffering from painful chronic conditions. To read Dr. Worthing’s op-ed in full, click here.
Last Updated on May 7, 2020 by Aimed Alliance
